Vascular News and Research

RSS

How flexing of blood vessels during a heartbeat might contribute to heart disease

Duke biomedical engineers have received more than $2.2 million from the National Institutes of Health (NIH) to continue their explorations of how the complex moving and flexing of blood vessels during a heartbeat might contribute to heart disease.

28 Apr 2004

Greater severity of depressive symptoms correlates with increased risk of stroke among whites

Greater severity of depressive symptoms correlates with increased risk of stroke among whites, according to research that will be presented at the American Academy of Neurology 56th Annual Meeting in San Francisco, Calif., April 24 – May 1, 2004.

28 Apr 2004

Carbohydrate-binding proteins are becoming extremely useful in curing various illnesses

Researchers are beginning to see the potential for breakthrough in healthcare through glycomics, which studies carbohydrates, proteins and their interactions. In fact, these carbohydrates are moving beyond their regular roles as sugar storage bins.

28 Apr 2004

CellCept linked to reduced cancer incidence

A study presented today at an international transplant meeting showed that heart transplant patients treated with the immunosuppressant CellCeptÒ (mycophenolate mofetil) in standard immunosuppressive regimens had a significantly lower risk of developing cancer compared to those receiving non-CellCept-based treatment regimens.

23 Apr 2004

Alzheimer Society of Canada new Alzheimer fact sheet

Dementia is a syndrome consisting of a number of symptoms that include loss of memory, judgment and reasoning, and changes in mood, behaviour and communication abilities. Alzheimer Disease, the most common form of dementia, accounts for 64 per cent of all dementias in Canada.

22 Apr 2004

FDA recommends approval of stenting to prevent stroke

Cordis Endovascular today reported the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) recommended approval of the company's new Cordis Carotid System. Cordis Endovascular is a division of Cordis Corporation, a Johnson & Johnson company.

21 Apr 2004

GE Introduces new imaging solution for diagnosing certain diseases

Patients can now experience increased peace-of-mind and enhanced expert care during cardiac and vascular treatment, thanks to a first-of-its-kind imaging system from GE Healthcare.

21 Apr 2004

New research findings about T-cell transport shed light on immune system

New research findings about T-cell transport shed light on how the normal immune system functions and could have implications in fighting autoimmune and inflammatory diseases, say researchers at University of Texas Southwestern Medical Center, Dallas.

20 Apr 2004

Pfizer donates £1 million Brighton and Sussex Medical School

Brighton and Sussex Medical School (BSMS) is pleased to announce that it has received a £1 million donation from pharmaceutical company, Pfizer (UK).

20 Apr 2004

Repeated pregnancies may increase cardiovascular disease

The study was designed to measure the blood pressure responses to phenylephrine and to acute stress in conscious age-matched repeatedly breed (RB) and virgin rats.

19 Apr 2004

New scanning technology allows researchers to look into a kidney

Kidney disease may affect as many as one in twelve people, and causes millions of deaths each year. Currently, the diagnosis of kidney function relies mainly on blood and urine tests, an indirect means of figuring out how well they’re working.

19 Apr 2004

Researchers find drug that may suppress genetic mutation using a novel screening approach

Researchers at Massachusetts General Hospital have developed a way of identifying promising new drugs that may get around a major challenge in drug discovery.

18 Apr 2004

Bad hygiene may be good for you

A group of scientists at The Scripps Research Institute have found a connection between poor T cell survival in the body and the development of autoimmunity.

16 Apr 2004

Obese mothers increase likelihood of pre-eclampsia

A research team from the University of Glasgow has been awarded nearly £129, 000 by the British Heart Foundation (BHF) to investigate the cause of pre-eclampsia (PE), a condition that kills nearly 600 babies in the UK each year.

14 Apr 2004

A new system of health and wellbeing

Hands up who goes to the doctor when they are feeling well? Hands up who goes to the doctor just to chat about how they can stay well? The fact is most of us drag ourselves off to the doctor only when there are signs of trouble, when we are feeling sick.

14 Apr 2004

Mercy Hospital opens new cardiovascular catheterization laboratory

The $40 million expansion of The Cardiac Centers of Mercy & Unity Hospitals reaches a significant milestone this week with the opening of the most technologically advanced cardiovascular catheterization laboratories in Minnesota.

13 Apr 2004

Kentucky's first robotic procedure treats prostate

Earlier this year, the University of Kentucky Hospital was the first hospital in Kentucky to perform a minimally invasive, coronary artery bypass graft using surgical robotic instruments.

12 Apr 2004

Intensive diabetes management yields positive results

Increasing diabetes awareness and integrating a multi-faceted, approach to improve patient care and education, results in significantly improved patient outcomes, according to a report in the April issue of Clinical Diabetes, a publication of the American Diabetes Association.

7 Apr 2004

Oral sildenafil improved exercise tolerance, cardiac output and quality of life in 22 patients with primary pulmonary hypertension

Oral sildenafil (Viagra®) improved exercise tolerance, cardiac output and quality of life in 22 patients with primary pulmonary hypertension, according to the results of the first randomized, placebo-controlled, double-blind, crossover study, reported in the April 7, 2004 issue of the Journal of the American College of Cardiology.

6 Apr 2004

Cordis Cardiology receives warning from the U.S. Food and Drug Administration

Cordis Cardiology, a division of Cordis Corporation, a Johnson & Johnson Company, reported today that it received a warning letter from the U.S. Food and Drug Administration (FDA) regarding FDA's observations concerning the Good Manufacturing Practice (GMP) regulations.

5 Apr 2004